Elevated substance-P-like immunoreactivity levels in spinal dialysates during the formalin test in normal and diabetic rats
- 14 February 2000
- journal article
- Published by Elsevier in Brain Research
- Vol. 856 (1-2) , 20-27
- https://doi.org/10.1016/s0006-8993(99)02345-8
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Effects of diabetes on tissue content and evoked release of calcitonin gene-related peptide-like immunoreactivity from rat sensory nervesNeuroscience Letters, 1998
- Primary afferent tachykinins are required to experience moderate to intense painNature, 1998
- Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocainePain, 1996
- Different effects of two aldose reductase inhibitors on nociception and prostaglandin EEuropean Journal of Pharmacology, 1995
- Tolrestat treatment prevents modification of the formalin test model of prolonged pain in hyperglycemic ratsPain, 1994
- Multiple molecular forms of tachykinins in rat spinal cord: a study comparing different extraction methodsRegulatory Peptides, 1994
- The non‐peptide NK1 receptor antagonist, (±)‐CP‐96,345, produces antinociceptive and anti‐oedema effects in the ratBritish Journal of Pharmacology, 1992
- Axonal transport of substance P-like immunoreactivity in ganglioside-treated diabetic ratsJournal of the Neurological Sciences, 1990
- In vivo release of substance P in cat dorsal horn studied with microdialysisNeuroscience Letters, 1987
- Tachykinin multiplicity in rat central nervous system as studied using antisera raised against substance P and neurokinin ARegulatory Peptides, 1986